Why is Welcure Drugs falling/rising?

As of 28-Aug, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 10.24, reflecting a decrease of 0.53 or 4.92%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a significant drop of 18.34% over the past week. Today's performance shows that it has underperformed its sector by 4.08%. Despite having positive financial results in recent quarters, including a remarkable growth in net sales and profits, the stock's current movement is negatively impacted by a substantial decrease in investor participation, with delivery volume plummeting by 95.27% against the five-day average.
In the broader market context, while the Sensex has only declined by 2.34% over the past week, Welcure's performance has been significantly worse. The stock has shown a year-to-date decline of 12.25%, contrasting with the Sensex's gain of 2.48%. Although the company has demonstrated strong growth metrics and has outperformed the market over the past year with a return of 39.70%, the recent poor management efficiency indicated by a low return on equity of 3.58% may be contributing to investor concerns, leading to the current downward trend in stock price.